1420 N. Claremont Boulevard
Synedgen is well-positioned to lead the industry in the advancement of modified polysaccharides for therapeutic use. We are aggressively moving toward the clinic with numerous programs in the research or pre-clinical development stages.
Founder and CEO: William Wiesmann
Founder and COO: Shenda Baker
Please click here for Synedgen job opportunities.
Please click here for clinical trial information.